PC
BSX icon

Paulson & Co’s Boston Scientific BSX Stock Holding History

Paulson & Co’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-288,000
Closed -$6.23M – 101
2016
Q4 		$6.23M Sell
288,000
-122,000
-30% -$2.66M 0.08% 73
2016
Q3 		$9.76M Buy
410,000
+316,000
+336% +$7.54M 0.11% 61
2016
Q2 		$2.2M Buy
94,000
+20,000
+27% +$433K 0.02% 73
2016
Q1 		$1.39M Buy
+74,000
New +$1.3M 0.01% 88

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Paulson & Co's BSX Position: Q1 2017 in Review

Paulson & Co sold out of Boston Scientific (BSX) in Q1 2017, closing a stake of 288,000 shares — an estimated $6.23M sold.

Paulson & Co first reported a position in BSX in Q1 2016 and held it in 4 quarters. The position peaked at $9.76M in Q3 2016. 552 funds tracked by Wall St. Rank hold BSX as of Q1 2017.

  • Paulson & Co reported no remaining Boston Scientific position as of Q1 2017 after selling out during the quarter.
  • Paulson & Co sold 288,000 Boston Scientific shares in Q1 2017, an estimated $6.23M.
  • Paulson & Co first reported a position in Boston Scientific in Q1 2016 and held it in 4 quarters.
  • Paulson & Co's Boston Scientific position peaked at $9.76M in Q3 2016.
  • 552 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2017.

Based on Paulson & Co's 13F filing for Q1 2017, filed 15 May 2017.